Trimethylamine → 1,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one

HRID 2260831Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 2260831
CC1N([CH2:7][CH:8]2[C:21](=[O:22])[C:12]3[C:13]4[CH:14]=[CH:15][CH:16]=[CH:17][C:18]=4[N:19]([CH3:20])[C:11]=3[CH2:10][CH2:9]2)C=CN=1.CI.CN(C)C>>[CH3:20][N:19]1[C:11]2[CH2:10][CH2:9][C:8](=[CH2:7])[C:21](=[O:22])[C:12]=2[C:13]2[C:18]1=[CH:17][CH:16]=[CH:15][CH:14]=2

Komponenten

4

Edukt 3

HCID 1146TrimethylamineHCID 4595OndansetronHCID 6328Methyl iodide

Produkt 1

HCID 117905051,2,3,9-Tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one

Versuchsvorschrift

Peculiarly, the above-said patent specification indicates this tertiary amine to be known per se and, in addition, ondansetron can be prepared therefrom in an other way, too. After quaternizing the tertiary amine with methyl iodide, trimethylamine is split off from the obtained methoiodide by Hofmann's elimination reaction to give 9-methyl-3-methylene-1,2,3,9-tetrahydro-4H-carbazol-4-one. The thus-obtained electrophilic conjugated enone is subjected to an addition reaction with 2-methylimidazole (see Example 8 of the specification). The surprisingly moderate yield of 43.2% of the reaction shows that the significance of this simple direct addition, starting from the separated enone, should not be overestimated.

Aufarbeitung

  1. customcan be prepared
  2. customis split off from the obtained methoiodide by Hofmann's elimination reaction

Quellen und Nachweise

ORD-Eintrag
ord-a997494b455344708f3694c2a9d1eec4
Quelldatensatz
uspto-grants-1995_12
Patentnummer
US05478949

Notizen zur Reaktion

Wird geladen…